Literature DB >> 8213811

Overexpression of esterase D in kidney from trisomy 13 fetuses.

S Loughna1, P Bennett, G Gau, K Nicolaides, S Blunt, G Moore.   

Abstract

Human trisomy 13 (Patau syndrome) occurs in approximately 1 in 5,000 live births. It is compatible with life, but prolonged survival is rare. Anomalies often involve the urogenital, cardiac, craniofacial, and central nervous systems. It is possible that these abnormalities may be due to the overexpression of developmentally important genes on chromosome 13. The expression of esterase D (localized to chromosome 13q14.11) has been investigated in both muscle and kidney from trisomy 13 fetuses and has been compared with normal age- and sex-matched fetal tissues, by using northern analysis. More than a twofold increase in expression of esterase D was found in the kidney of two trisomy 13 fetuses, with normal levels in a third. Overexpression was not seen in the muscle tissues from these fetuses.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8213811      PMCID: PMC1682378     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  28 in total

1.  Multiple congenital anomaly caused by an extra autosome.

Authors:  K PATAU; D W SMITH; E THERMAN; S L INHORN; H P WAGNER
Journal:  Lancet       Date:  1960-04-09       Impact factor: 79.321

2.  Evidence for a null allele at the esterase D (EC 3.1.1.1) locus.

Authors:  R S Sparkes; S Targum; E Gershon; G F Sensabaugh; M C Sparkes; M Crist
Journal:  Hum Genet       Date:  1979-02-15       Impact factor: 4.132

3.  Esterase D: a new human polymorphism.

Authors:  D A Hopkinson; M A Mestriner; J Cortner; H Harris
Journal:  Ann Hum Genet       Date:  1973-10       Impact factor: 1.670

4.  Clinical delineation of proximal and distal partial 13q trisomy.

Authors:  J F Rogers
Journal:  Clin Genet       Date:  1984-03       Impact factor: 4.438

5.  Protein variations associated with Down's syndrome, chromosome 21, and Alzheimer's disease.

Authors:  M L Van Keuren; D Goldman; C R Merril
Journal:  Ann N Y Acad Sci       Date:  1982       Impact factor: 5.691

6.  A fetal skeletal muscle actin mRNA in the mouse and its identity with cardiac actin mRNA.

Authors:  A J Minty; S Alonso; M Caravatti; M E Buckingham
Journal:  Cell       Date:  1982-08       Impact factor: 41.582

7.  The world distribution of the electrophoretic variants of the red cell enzyme esterase D.

Authors:  S S Papiha; A Nahar
Journal:  Hum Hered       Date:  1977       Impact factor: 0.444

8.  Quantitative variations in polymorphic types of human red cell esterase D.

Authors:  I Nishigaki; T Itoh; N Ogasawara
Journal:  Ann Hum Genet       Date:  1983-07       Impact factor: 1.670

9.  Retinoblastoma, deletion 13q14, and esterase D: application of gene dosage effect to prenatal diagnosis.

Authors:  C Junien; S Despoisse; C Turleau; H Nicolas; F Picard; B Le Marec; J C Kaplan; J de Grouchy
Journal:  Cancer Genet Cytogenet       Date:  1982-08

10.  Isolation and characterization of full-length cDNA clones for human alpha-, beta-, and gamma-actin mRNAs: skeletal but not cytoplasmic actins have an amino-terminal cysteine that is subsequently removed.

Authors:  P Gunning; P Ponte; H Okayama; J Engel; H Blau; L Kedes
Journal:  Mol Cell Biol       Date:  1983-05       Impact factor: 4.272

View more
  2 in total

1.  Molecular analysis of the expression of transthyretin in intestine and liver from trisomy 18 fetuses.

Authors:  S Loughna; P Bennett; G Moore
Journal:  Hum Genet       Date:  1995-01       Impact factor: 4.132

2.  The nephrogenic potential of the transcription factors osr1, osr2, hnf1b, lhx1 and pax8 assessed in Xenopus animal caps.

Authors:  Christiane Drews; Sabine Senkel; Gerhart U Ryffel
Journal:  BMC Dev Biol       Date:  2011-01-31       Impact factor: 1.978

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.